We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.75B
AUM Growth
+$282M
Cap. Flow
+$98.4M
Cap. Flow %
3.57%
Top 10 Hldgs %
25.32%
Holding
537
New
191
Increased
80
Reduced
82
Closed
170

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$61.8M
2
TJX icon
TJX Companies
TJX
+$44.7M
3
UBER icon
Uber
UBER
+$43.5M
4
STZ icon
Constellation Brands
STZ
+$38M
5
PYPL icon
PayPal
PYPL
+$34.2M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 12.59%
3 Industrials 10.36%
4 Healthcare 6.17%
5 Communication Services 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
226
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$1.52M 0.06%
+46,570
New +$1.57M
BMRN icon
227
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.52M 0.06%
+17,500
New +$1.65M
SPOT icon
228
Spotify
SPOT
$103B
$1.51M 0.05%
9,395
-102,998
-92% -$14.9M
PTGX icon
229
CALL
Protagonist Therapeutics
PTGX
$8.79B
$1.49M 0.05%
+54,000
New +$1.35M
CELC icon
230
Celcuity
CELC
$4.21B
$1.48M 0.05%
+135,000
New +$1.4M
PINS icon
231
Pinterest
PINS
$13.4B
$1.42M 0.05%
+51,970
New +$1.3M
IFRX icon
232
InflaRx
IFRX
$250M
$1.39M 0.05%
+312,142
New +$1.4M
TGTX icon
233
CALL
TG Therapeutics
TGTX
$7.96B
$1.34M 0.05%
+54,000
New +$1.39M
ACRS icon
234
CALL
Aclaris Therapeutics
ACRS
$726M
$1.33M 0.05%
+128,200
New +$1.16M
REPL icon
235
Replimune Group
REPL
$941M
$1.33M 0.05%
57,120
-46,603
-45% -$911K
ILPT
236
Industrial Logistics Properties Trust
ILPT
$575M
$1.3M 0.05%
392,794
+32,572
+9% +$72.7K
SAVE
237
DELISTED
Spirit Airlines, Inc.
SAVE
$1.29M 0.05%
+75,146
New +$1.23M
AMLP icon
238
Alerian MLP ETF
AMLP
$13B
$1.26M 0.05%
+32,166
New +$1.25M
PRPL icon
239
Purple Innovation
PRPL
$35.3M
$1.25M 0.05%
+17,947
New +$1.29M
APLS
240
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$1.23M 0.04%
+13,500
New +$1.16M
PERI icon
241
PUT
Perion Network
PERI
$375M
$1.19M 0.04%
+38,900
New +$1.34M
SNOW icon
242
PUT
Snowflake
SNOW
$102B
$1.18M 0.04%
6,700
-47,300
-88% -$7.69M
AXSM icon
243
Axsome Therapeutics
AXSM
$11.2B
$1.15M 0.04%
15,946
-46,405
-74% -$3.42M
CR icon
244
Crane Co
CR
$12.3B
$1.14M 0.04%
+12,764
New +$985K
BMY icon
245
PUT
Bristol-Myers Squibb
BMY
$133B
$1.12M 0.04%
+17,500
New +$1.17M
SHOP icon
246
CALL
Shopify
SHOP
$152B
$1.12M 0.04%
17,300
+10,600
+158% +$599K
METCB icon
247
Ramaco Resources Class B
METCB
$425M
$1.12M 0.04%
+113,476
New +$1.1M
MTCH icon
248
Match Group
MTCH
$9.19B
$1.08M 0.04%
25,922
+18,992
+274% +$694K
WEX icon
249
WEX
WEX
$6.37B
$1.08M 0.04%
5,938
-26,053
-81% -$4.61M
TARS icon
250
Tarsus Pharmaceuticals
TARS
$2.58B
$1.01M 0.04%
55,972
+14,399
+35% +$229K

Similar funds

J. Goldman & Co's Q2 2023 Portfolio in Review

As of Q2 2023, J. Goldman & Co held 537 positions worth $2.75B, up 11% from $2.47B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

J. Goldman & Co deployed $98.4M of net new capital in Q2 2023, opening 191 new positions and adding to 80 existing holdings. Its largest new stake was Splunk Inc: 342,083 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Uber, an estimated $43.5M trimmed.

  • J. Goldman & Co's largest Q2 2023 buy was Splunk Inc: 342,083 shares worth $36.3M.
  • J. Goldman & Co added most to iShares Russell 2000 ETF in Q2 2023, an estimated $44.3M increase.
  • J. Goldman & Co's biggest Q2 2023 reduction was Uber, cutting an estimated $43.5M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q2 2023, selling an estimated $61.8M.
  • J. Goldman & Co's ten largest holdings make up 25% of its $2.75B portfolio in Q2 2023.
  • J. Goldman & Co opened 191 new positions and closed 170 in Q2 2023.
  • J. Goldman & Co's portfolio value rose 11% quarter-over-quarter to $2.75B.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.